<p>As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into Europe’s exclusive $1 billion biotech club, alongside the likes of Abivax and Medincell. They also chat about what it means to partner with giants like Johnson &amp; Johnson, and how Laurent’s leadership style has evolved over his long tenure.</p><p>⭐️ ABOUT THE SPEAKERLaurent Lévy co-founded Nanobiotics in 2003 and has served as CEO ever since. Before this, he worked in a variety of roles with companies including Altran Technologies, Valbiotis and Sanofi.He has a doctorate in nanomaterials-focused physical chemistry from the Pierre and Marie Curie University in Paris.</p><p>🔗 LINKS MENTIONED</p><ul><li>Nanobiotix website -- <a href="https://nanobiotix.com/" target="_blank" rel="noopener noreferer">https://nanobiotix.com/</a></li><li>Nanobiotix&#39;s $71 million deal with Healthcare Royalty -- <a href="https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-strategic-royalty-monetization-agreement" target="_blank" rel="noopener noreferer">https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-strategic-royalty-monetization-agreement</a></li><li>Nanobiotix&#39;s first phase 1 data -- <a href="https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-first-data-phase-1-study-evaluating-jnj" target="_blank" rel="noopener noreferer">https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-first-data-phase-1-study-evaluating-jnj</a></li></ul><p><br></p><p><br></p><p>📜 TRANSCRIPT</p><p>Read the full transcript here: <a href="https://flot.bio/episode/laurent-levy-nanobiotix-nanoparticles-radiotherapy/" target="_blank" rel="noopener noreferer">https://flot.bio/episode/laurent-levy-nanobiotix-nanoparticles-radiotherapy/</a></p><p>💸 DONATEWe welcome donations from individuals and businesses to support our podcast and allow us to create even more content: <a href="https://www.paypal.me/PhilipHemme" target="_blank" rel="noopener noreferer">https://www.paypal.me/PhilipHemme</a></p><p>⭐️ SPONSORSHIP</p><p>Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!</p><p>🫶 FOLLOW US</p><ul><li> Newsletter: <a href="http://eepurl.com/h_fnmH" target="_blank" rel="noopener noreferer">http://eepurl.com/h_fnmH</a></li><li>LinkedIn: <a href="https://www.linkedin.com/company/flot-bio/" target="_blank" rel="noopener noreferer">https://www.linkedin.com/company/flot-bio/</a></li><li>X (Twitter): <a href="https://x.com/FlotBio" target="_blank" rel="noopener noreferer">https://x.com/FlotBio</a></li></ul><p><br></p><p><br></p><p>🙏 LIKE/FOLLOW/REVIEW</p><p>Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.</p><p>🎙️ ABOUT FLOT.BIO</p><p>Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.</p><p>⏰ TIMESTAMPS</p><ul><li>[00:00:00] Intro</li><li>[00:02:11] Soaring stocks with clinical results</li><li>[00:04:08] Nanobiotix&#39;s history</li><li>[00:07:39] Nanoparticles and radiotherapy</li><li>[00:13:42] Developing NBTXR3</li><li>[00:25:02] Universal cancer radiotherapy enhancers</li><li>[00:28:28] Few competitors</li><li>[00:33:37] Biotech in France, Europe and the US</li><li>[00:37:19] Laurent Lévy’s leadership style</li><li>[00:42:16] Quick-fire questions</li></ul>